THC Therapeutics, Inc.
THCT
$0.0001
-$0.0002-66.67%
OTC PK
| 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 10.81% | -133.93% | 97.07% | -109.34% | 114.93% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | -55.56% | -90.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -63.58% | 124.41% | -100.60% | 91.39% | -136.75% |
| Change in Net Operating Assets | -48.33% | -64.23% | -12.53% | -26.10% | 17.45% |
| Cash from Operations | -6,131.82% | 26.90% | 98.60% | 100.00% | 97.76% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -92.00% | -99.10% | -100.00% | -100.00% |
| Total Debt Repaid | 100.00% | 98.59% | -- | 100.00% | -50.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,136.36% | -27.46% | -98.80% | -100.00% | -108.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.32% | -33.96% | -- | 100.00% | 58.88% |